Histadrut
Hospitals, clinics and family health centers: Nursing staff declare labor dispute
The Israeli Nurses Union has declared a labor dispute. The background: Claims of a low caregiver–to–patient ratio, cutbacks preventing manpower recruitment, and a severe shortage of hospital beds.
These are the big winners from the shortening of the workweek, and these are those who are harmed
Workers to receive 13.5% pay raise in new collective agreement
Sanctions at ILA Haifa: Public reception has been suspended
Three workmen fall as scaffolding collapses at construction site
No injuries were reported as a result of the accident.
Histadrut orders 'lifesaving' general strike as workplace casualties grow
"If we can't find a solution, there will be a tough strike," Histadrut head Avi Nissenkorn said.
Caregivers protest exploitation at demonstration in Tel Aviv
Over 150,000 patients receive service from 120,000 caregivers.
Firefighters protest ‘destructive behavior’ of commissioner
The firefighters are protesting “severe damage to their working conditions, in view of the harsh reality of their ongoing activities in the past year, primarily the war on incendiary kites."
District court mediates end to paramedical workers’ strike
During the hearing, the judge expressed solidarity with the workers’ struggle.
Paramedical workers to continue strike
The Histadrut labor federation and Eli Gabai, the head of the health workers union in the federation, provided a specific reason for the strike.
Israelis to enjoy one less hour of work per week
Starting April 1, the workweek will be cut to 42 hours, after which employees will get paid overtime.
Teva delays 33% of Jerusalem layoffs until 2019
The company making its first gesture, albeit a small one, to the workers and the Histadrut.
Jerusalem's Teva turmoil
There are some 1,780 Jerusalemites employed at the city’s two branches of Teva, which for decades has been one of the country’s greatest industrial success stories.
Is Teva’s downfall pharma’s Lavi moment?
If done right, Israel could turn the Teva crisis from a misfortune into an opportunity.